Jiangsu Hengrui Medicine Co., Ltd.;Shanghai Hengrui Pharmaceutical Co., Ltd.
发明人:
申请号：
EP18892762.8
公开号：
EP3714901A1
申请日:
2018.12.21
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed are a lymphocyte-activation gene 3 (LAG-3) antibody pharmaceutical composition and the use thereof. The pharmaceutical composition comprises a LAG-3 antibody or an antigen-binding fragment thereof in an acetate buffer or in a histidine salt buffer. The pharmaceutical composition may also comprise saccharide, non-ionic surfactant and other excipients.
